[HTML][HTML] PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
D Miricescu, A Totan, II Stanescu-Spinu… - International Journal of …, 2020 - cir.nii.ac.jp
抄録< jats: p> Breast cancer is a serious health problem worldwide, representing the second
cause of death through malignancies among women in developed countries. Population …
cause of death through malignancies among women in developed countries. Population …
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
D Miricescu, A Totan… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
D Miricescu, A Totan, II Stanescu-Spinu, SC Badoiu… - 2021 - agris.fao.org
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
[PDF][PDF] PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
D Miricescu, A Totan, II Stanescu-Spinu… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
[HTML][HTML] PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
D Miricescu, A Totan, II Stanescu-Spinu… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects.
D Miricescu, A Totan, II Stanescu-Spinu… - … Journal of Molecular …, 2020 - europepmc.org
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
D Miricescu, A Totan, II Stanescu-Spinu… - Int. J. Mol …, 2021 - search.proquest.com
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
[PDF][PDF] PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
D Miricescu, A Totan, II Stanescu-Spinu, SC Badoiu… - Int. J. Mol. Sci, 2021 - academia.edu
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects.
D Miricescu, A Totan… - International …, 2021 - search.ebscohost.com
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …